Medtronic Inc. (MDT): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic ( MDT) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 1.4%. By the end of trading, Medtronic fell $1.12 (-1.9%) to $56.26 on average volume. Throughout the day, 3,967,263 shares of Medtronic exchanged hands as compared to its average daily volume of 3,867,400 shares. The stock ranged in price between $56.20-$57.43 after having opened the day at $57.39 as compared to the previous trading day's close of $57.38. Other companies within the Health Services industry that declined today were: Opko Health ( OPK), down 14.7%, Laboratory Corporation of America Holdings ( LH), down 11.0%, Organovo Holdings ( ONVO), down 10.7% and Huttig Building Products ( HBP), down 8.7%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $57.8 billion and is part of the health care sector. The company has a P/E ratio of 15.5, below the S&P 500 P/E ratio of 17.7. Shares are up 41.1% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, BG Medicine ( BGMD), up 30.6%, Select Medical Holdings Corporation ( SEM), up 18.1%, BioTelemetry ( BEAT), up 8.6% and Kindred Healthcare ( KND), up 7.8%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers